Orthopedic Surgery Doctors in Basalt, CO Accepting Medicare

4 Orthopedic Surgery doctors found. Showing 1 - 4

Ferdinand Jesus Liotta, M.D. Orthopaedic Surgery - Sports Medicine Medicare: Accepting Medicare Assignments Practice Location: 1450 E Valley Rd, Suite 201, Basalt, CO 81621 Phone: 970-927-8611    Fax: 970-927-8633

Tomas Pevny, MD Orthopaedic Surgery - Sports Medicine Medicare: Accepting Medicare Assignments Practice Location: 1450 E Valley Rd, Suite 201, Basalt, CO 81621 Phone: 970-927-8611    Fax: 970-927-8633

Thomas P Moore, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 100 Elk Run Dr Ste 229, Basalt, CO 81621 Phone: 970-927-3344    Fax: 970-927-9555

Dr. Stanley Gertzbein, M.D. Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 670 Frying Pan Rd, Basalt, CO 81621 Phone: 713-269-2266

News Archive

Viewpoints: Support for drug benefit merger; Health reform comes too slowly for some patients; Pinpointing Romney's views on mandate

It seems counterintuitive, but the Federal Trade Commission has just decided that a $29 billion merger of two of the three largest companies that manage pharmaceutical benefits for employers and health plans -; Express Scripts and Medco Health Solutions -; would not substantially lessen competition. That judgment deserves credence because of the thoroughness of the F.T.C.'s eight-month inquiry and the willingness of the agency to oppose other mergers when the evidence warrants.

Helmholtz Zentrum München appoints Professor Matthias Tschöp as new CEO

Professor Matthias Tschöp, MD, has been appointed the new CEO of Helmholtz Zentrum München. He took over from Professor Günther Wess, who led the center for the past 13 years.

USFDA approves Dr. Reddy's ANDA for Fondaparinux Sodium Injection

Dr. Reddy's Laboratories and Alchemia Limited, Brisbane, Australia announced today that Dr. Reddy's has received final approval of Dr. Reddy's ANDA for Fondaparinux Sodium Injection, a bioequivalent generic version of Arixtra, in the US market on July 11, 2011 by the United States Food & Drug Administration.

Promising anti-malarial compound uses novel mechanism to kill malaria parasite

An international research collaborative has determined that a promising anti-malarial compound tricks the immune system to rapidly destroy red blood cells infected with the malaria parasite but leave healthy cells unharmed. St. Jude Children's Research Hospital scientists led the study, which appears in the current online early edition of the Proceedings of the National Academy of Sciences.

Elderly and ill patients connect to their doctors via broadband: Pilot Australian project

Now elderly patients and severely ill cancer patients will be able to see their specialist or GP with the click of a mouse, even if they are hundreds of kilometres away. This will be possible with a $20.6 million pilot program that starts this July. The program will use the national broadband network to deliver telehealth services to older Australians, cancer patients and those in palliative care.

Read more Medical News

› Verified 5 days ago